X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5460) 5460
humans (2747) 2747
animals (2484) 2484
cytosine - analogs & derivatives (1217) 1217
mice (1064) 1064
male (997) 997
female (988) 988
pharmacology & pharmacy (981) 981
oncology (892) 892
biochemistry & molecular biology (761) 761
cytosine (665) 665
rats (648) 648
cytosine - pharmacology (639) 639
cytosine-arabinoside (622) 622
methylation (546) 546
dna (532) 532
dna methylation (530) 530
cytosine - metabolism (516) 516
kinetics (506) 506
cancer (466) 466
cytosine nucleotides - pharmacology (444) 444
adult (419) 419
cytarabine - pharmacology (415) 415
antiviral agents - pharmacology (413) 413
cell line (394) 394
time factors (387) 387
cell line, tumor (381) 381
cytosine nucleotides - metabolism (369) 369
tritium (361) 361
cytosine deaminase (356) 356
antineoplastic agents - pharmacology (352) 352
middle aged (351) 351
research (351) 351
expression (336) 336
flucytosine - pharmacology (336) 336
cells (333) 333
base sequence (327) 327
mutation (326) 326
dose-response relationship, drug (323) 323
cells, cultured (318) 318
tumor cells, cultured (317) 317
gene expression (291) 291
genetics & heredity (285) 285
cytosine arabinoside (280) 280
dna - metabolism (276) 276
cytosine - therapeutic use (274) 274
microbiology (270) 270
organophosphonates (270) 270
cidofovir (267) 267
aged (263) 263
cytosine - chemistry (263) 263
hematology (261) 261
chemotherapy (260) 260
carbon isotopes (253) 253
cytosine nucleotides (251) 251
biotechnology & applied microbiology (250) 250
molecular sequence data (249) 249
pyrimidines (246) 246
cell biology (244) 244
in-vitro (243) 243
medicine, research & experimental (242) 242
therapy (239) 239
analysis (238) 238
genes (230) 230
pharmacology (228) 228
apoptosis (227) 227
in vitro techniques (227) 227
azacitidine - pharmacology (225) 225
escherichia coli - enzymology (223) 223
5-methylcytosine (219) 219
hydrogen-ion concentration (219) 219
in-vivo (219) 219
acute myelogenous leukemia (214) 214
acute myeloid-leukemia (214) 214
virology (212) 212
cell survival - drug effects (211) 211
cytosine deaminase - genetics (211) 211
genetic aspects (210) 210
enzymes (209) 209
article (205) 205
antiviral agents - therapeutic use (200) 200
cell division - drug effects (197) 197
cytarabine (197) 197
antimetabolites, antineoplastic - pharmacology (193) 193
cytarabine - administration & dosage (191) 191
structure-activity relationship (188) 188
deoxyribonucleic acid--dna (187) 187
epigenetics (182) 182
health aspects (182) 182
magnesium - pharmacology (182) 182
enzyme inhibitors - pharmacology (180) 180
proteins (180) 180
binding sites (179) 179
chemistry, medicinal (177) 177
leukemia (177) 177
rna (177) 177
gene therapy (175) 175
viruses (175) 175
ara-c (174) 174
organophosphonates - pharmacology (173) 173
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5639) 5639
Russian (81) 81
German (48) 48
Japanese (41) 41
French (36) 36
Chinese (35) 35
Italian (7) 7
Polish (7) 7
Spanish (3) 3
Portuguese (2) 2
Swedish (2) 2
Czech (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pancreas, ISSN 0885-3177, 08/2015, Volume 44, Issue 6, pp. 945 - 952
Objectives The bleak prognosis associated with pancreatic cancer (PDAC) drives the need for the development of novel treatment methodologies. Here, we evaluate... 
5-fluorouracil | phosphatidylserine | pancreatic cancer | methylselenol | 2-fluoroadenine | enzyme prodrug therapy | annexin V | L-METHIONINASE | PURINE NUCLEOSIDE PHOSPHORYLASE | CONTAINING FUSION PROTEIN | PHASE-II | TUMOR-CELLS | MONOCLONAL-ANTIBODY | BREAST-CANCER | CYTOSINE DEAMINASE | PROSTATE-CANCER | GENE-THERAPY | GASTROENTEROLOGY & HEPATOLOGY | Adenocarcinoma - pathology | Taxoids - pharmacology | Tubulin Modulators - pharmacology | Humans | Methanol - analogs & derivatives | Molecular Targeted Therapy | Recombinant Fusion Proteins - metabolism | Organoselenium Compounds - pharmacology | Prodrugs - metabolism | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | Pancreatic Neoplasms - drug therapy | Cytosine Deaminase - metabolism | Cell Death - drug effects | Purine-Nucleoside Phosphorylase - metabolism | Vidarabine - metabolism | Enzymes - metabolism | Fluorouracil - metabolism | Selenomethionine - metabolism | Selenomethionine - pharmacology | Adenine - analogs & derivatives | Methanol - pharmacology | Pancreatic Neoplasms - pathology | Adenocarcinoma - enzymology | Pancreatic Neoplasms - enzymology | Adenine - pharmacology | Vidarabine - analogs & derivatives | Adenocarcinoma - drug therapy | Carbon-Sulfur Lyases - metabolism | Flucytosine - metabolism | Methanol - metabolism | Vidarabine - pharmacology | Annexin A5 - metabolism | Cell Line, Tumor | Adenine - metabolism | Fluorouracil - pharmacology | Flucytosine - pharmacology | Prodrugs - pharmacology | Organoselenium Compounds - metabolism | Index Medicus
Journal Article
BMC Pharmacology and Toxicology, ISSN 2050-6511, 06/2013, Volume 14, Issue 1, pp. 32 - 32
Background: Dormant cells are characterised by low RNA synthesis. In contrast, cancer cells can be addicted to high RNA synthesis, including synthesis of... 
Dormancy | Leukemia | RNA polymerase II inhibitors | PROGENITOR CELLS | CYTOSINE-ARABINOSIDE | COLONY-STIMULATING FACTOR | TRANSCRIPTION | DOWN-REGULATION | MYELOBLASTIC-LEUKEMIA | P-GLYCOPROTEIN | R-ROSCOVITINE | HEMATOPOIETIC STEM-CELLS | PHARMACOLOGY & PHARMACY | TOXICOLOGY | FLAVOPIRIDOL | Cytarabine - pharmacology | TOR Serine-Threonine Kinases - metabolism | Adenine Nucleotides - pharmacology | Apoptosis - drug effects | Humans | Leukemia, Myeloid - genetics | Daunorubicin - pharmacology | RNA Polymerase II - metabolism | RNA, Neoplasm - metabolism | Heterocyclic Compounds, 4 or More Rings - pharmacology | Dose-Response Relationship, Drug | Leukemia, Myeloid - pathology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Piperidines - pharmacology | Antineoplastic Agents - pharmacology | Flavonoids - pharmacology | Cell Survival - drug effects | Acute Disease | RNA Polymerase II - antagonists & inhibitors | Purines - pharmacology | Enzyme Inhibitors - pharmacology | Etoposide - pharmacology | Arabinonucleosides - pharmacology | Sirolimus - pharmacology | Azacitidine - pharmacology | Leukemia, Myeloid - metabolism | Cell Line, Tumor | RNA, Neoplasm - genetics | Anthracyclines | Synthesis | RNA | Heterocyclic compounds | Analysis | Physiological aspects | Etoposide | Apoptosis | DNA | Nucleosides | Flow cytometry | Phosphorylation | Bone marrow | Kinases | Gene expression | Experiments | Cancer therapies | Patients | Pharmaceuticals | Cancer | Index Medicus
Journal Article
Veterinary and Comparative Oncology, ISSN 1476-5810, 06/2019, Volume 17, Issue 2, pp. 165 - 173
Journal Article
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2014, Volume 37, Issue 5, pp. 802 - 807
Journal Article
Journal Article
Blood, ISSN 0006-4971, 05/2003, Volume 101, Issue 9, pp. 3628 - 3634
Journal Article
Journal of Biomedical Science, ISSN 1021-7770, 01/2016, Volume 23, Issue 1, pp. 15 - 15
Journal Article